Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pluristem shares jump 5.4% premarket as FDA approves trial of treatment for critical limb ischemia
Pluristem shares jump 5.4% premarket as FDA approves trial of treatment for critical limb ischemia
Pluristem shares jump 5.4% premarket as FDA approves trial of treatment for critical limb ischemia
Submitted by
admin
on January 10, 2017 - 9:18am
Source:
Marketwatch
News Tags:
Pluristem
FDA
PLX-PAD
clinical trials
critical limb ischemia
Headline:
Pluristem shares jump 5.4% premarket as FDA approves trial of treatment for critical limb ischemia
Do Not Allow Advertisers to Use My Personal information
